These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 10573510

  • 1. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
    Higashi M, Yonezawa S, Ho JJ, Tanaka S, Irimura T, Kim YS, Sato E.
    Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
    [Abstract] [Full Text] [Related]

  • 2. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
    Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, Aiko T, Tanaka S, Irimura T, Kim YS, Sato E.
    Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
    [Abstract] [Full Text] [Related]

  • 3. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
    Yonezawa S, Sato E.
    Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
    [Abstract] [Full Text] [Related]

  • 4. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
    Shibahara H, Tamada S, Higashi M, Goto M, Batra SK, Hollingsworth MA, Imai K, Yonezawa S.
    Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
    [Abstract] [Full Text] [Related]

  • 5. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.
    Zen Y, Sasaki M, Fujii T, Chen TC, Chen MF, Yeh TS, Jan YY, Huang SF, Nimura Y, Nakanuma Y.
    J Hepatol; 2006 Feb; 44(2):350-8. PubMed ID: 16360234
    [Abstract] [Full Text] [Related]

  • 6. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis.
    Tamada S, Goto M, Nomoto M, Nagata K, Shimizu T, Tanaka S, Sakoda K, Imai K, Yonezawa S.
    Pathol Int; 2002 Nov; 52(11):713-23. PubMed ID: 12685548
    [Abstract] [Full Text] [Related]

  • 7. Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion.
    Ohtsuka M, Kimura F, Shimizu H, Yoshidome H, Kato A, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T, Suda K, Takano S, Kondo Y, Miyazaki M.
    Am J Surg Pathol; 2011 Apr; 35(4):512-21. PubMed ID: 21412069
    [Abstract] [Full Text] [Related]

  • 8. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
    Barresi V, Vitarelli E, Grosso M, Tuccari G, Barresi G.
    Eur J Histochem; 2006 Apr; 50(4):301-9. PubMed ID: 17213039
    [Abstract] [Full Text] [Related]

  • 9. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.
    Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M.
    Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Iguchi T, Taketomi A, Maehara Y, Tsuneyoshi M.
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [Abstract] [Full Text] [Related]

  • 11. The expression of MUC mucin in cholangiocarcinoma.
    Mall AS, Tyler MG, Ho SB, Krige JE, Kahn D, Spearman W, Myer L, Govender D.
    Pathol Res Pract; 2010 Dec 15; 206(12):805-9. PubMed ID: 20947262
    [Abstract] [Full Text] [Related]

  • 12. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.
    Nakamura A, Horinouchi M, Goto M, Nagata K, Sakoda K, Takao S, Imai K, Kim YS, Sato E, Yonezawa S.
    J Pathol; 2002 Jun 15; 197(2):201-10. PubMed ID: 12015744
    [Abstract] [Full Text] [Related]

  • 13. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
    Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, Goggins M, Iocobuzio-Donahue C, Longnecker DS, Klimstra DS.
    Mod Pathol; 2002 Oct 15; 15(10):1087-95. PubMed ID: 12379756
    [Abstract] [Full Text] [Related]

  • 14. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
    Yonezawa S, Nakamura A, Horinouchi M, Sato E.
    J Hepatobiliary Pancreat Surg; 2002 Oct 15; 9(3):328-41. PubMed ID: 12353144
    [Abstract] [Full Text] [Related]

  • 15. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
    Tsai JH, Huang WC, Kuo KT, Yuan RH, Chen YL, Jeng YM.
    Histopathology; 2012 Dec 15; 61(6):1106-16. PubMed ID: 22882148
    [Abstract] [Full Text] [Related]

  • 16. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE, Wienand JR, Werner JP, Landsberg S, Drebber U, Hanisch FG, Dienes HP.
    Int J Oncol; 2005 Nov 15; 27(5):1289-97. PubMed ID: 16211224
    [Abstract] [Full Text] [Related]

  • 17. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
    Yu XW, Rong W, Xu FL, Xu GY, Sun YR, Feng MY.
    Ai Zheng; 2007 Nov 15; 26(11):1204-10. PubMed ID: 17991319
    [Abstract] [Full Text] [Related]

  • 18. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.
    Romani AA, Crafa P, Desenzani S, Graiani G, Lagrasta C, Sianesi M, Soliani P, Borghetti AF.
    BMC Cancer; 2007 Dec 21; 7():232. PubMed ID: 18154639
    [Abstract] [Full Text] [Related]

  • 19. Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions.
    Yeh TS, Tseng JH, Chen TC, Liu NJ, Chiu CT, Jan YY, Chen MF.
    Hepatology; 2005 Sep 21; 42(3):657-64. PubMed ID: 16116640
    [Abstract] [Full Text] [Related]

  • 20. [Intrahepatic cholangiocarcinoma: proposal of new macroscopic classification].
    Yamamoto J, Kosuge T, Shimada K, Takayama T, Yamasaki S, Ozaki H, Makuuchi M.
    Nihon Geka Gakkai Zasshi; 1993 Nov 21; 94(11):1194-200. PubMed ID: 8272051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.